Jordan JFDA Medical Device Registration Guide: Requirements, Process, and Timeline for Market Entry

A complete guide to registering medical devices and IVDs with Jordan's Food and Drug Administration (JFDA), covering classification, required documentation, the registration process, fees, timeline, and post-market obligations for foreign manufacturers.

Overview of Jordan's Medical Device Market

Jordan occupies a strategic position in the Middle Eastern healthcare landscape. Though a relatively small market by global standards, the country's medical device sector is growing steadily, driven by a young and expanding population, rising rates of non-communicable diseases, government investment in healthcare infrastructure, and an increasingly sophisticated regulatory framework. For foreign medical device manufacturers, Jordan represents a meaningful entry point into the Levant and broader Middle Eastern market.

The Jordanian medical device market is projected to reach US$362.10 million in revenue in 2024, with the largest segment being Cardiology Devices at US$55.93 million. Forecasts indicate a compound annual growth rate (CAGR) of 5.59% from 2024 to 2028, with the market expected to expand to US$450.10 million by 2028. Growth is fueled by government healthcare spending, increasing demand for advanced diagnostics and therapeutic technologies, and Jordan's role as a regional hub for medical tourism and healthcare services.

Jordan's healthcare system is a mixed public-private model. The public sector, anchored by the Ministry of Health, provides services to a large portion of the population through a network of hospitals and primary care centers. The private sector has grown substantially, with several major hospital groups and specialty clinics serving both Jordanian patients and medical tourists from across the region. This dual system creates demand across the full spectrum of medical devices, from basic consumables and surgical instruments to advanced cardiovascular implants, imaging systems, and diagnostic technologies.

The country is heavily import-dependent for medical technology. Domestic manufacturing is concentrated in lower-technology segments such as basic disposables and some surgical instruments. Most higher-technology devices -- imaging equipment, cardiovascular implants, orthopedic devices, advanced IVD reagents and instruments, and surgical robotics -- are imported. This import dependence creates a persistent and growing opportunity for foreign manufacturers across all device risk classes.

Jordan is also a participant in the Arab Harmonization Initiative, a regional effort to align pharmaceutical and medical device regulatory standards across Arab League member states. This initiative, coordinated through the Arab Industrial Development and Mining Organization (AIDMO), is working toward greater convergence of classification rules, registration requirements, and quality standards across the region. While full harmonization remains a work in progress, Jordan's engagement with the initiative signals its commitment to international regulatory best practices and provides a foundation for potential regional market leverage in the future.

For manufacturers who have already navigated the US FDA, EU MDR, or Saudi SFDA registration processes, Jordan's system will feel familiar in many respects. The JFDA accepts both EU and FDA classification models, relies on CE marking and FDA clearance as the basis for registration, and structures its requirements around internationally recognized quality and safety standards. However, Jordan has its own specific documentation requirements, authorized representative structure, labeling expectations, and post-market obligations that require dedicated preparation.

Related: For a broader understanding of medical device registration in the Middle East region, see our guide to medical device registration in Saudi Arabia, UAE, and the GCC.

Regulatory Authority and Legal Framework

The Jordan Food and Drug Administration (JFDA)

The Jordan Food and Drug Administration (JFDA) is the national regulatory authority responsible for ensuring the safety, quality, and efficacy of food, pharmaceuticals, and medical devices in Jordan. Established in 2003, the JFDA operates as an independent public sector regulatory institution under the umbrella of the Ministry of Health (MOH).

The JFDA's principal objectives are to ensure that:

Food is safe, wholesome, and properly labelled
Drugs are safe and efficacious
All products explicitly stated in the enforced drug and pharmacy law meet applicable safety standards

For medical devices specifically, the JFDA's responsibilities include:

Pre-market registration and evaluation of medical devices and in vitro diagnostics (IVDs)
Classification review to determine the appropriate risk class for each device
Quality system oversight, including review of ISO certification and GMP compliance documentation
Supervision and inspection of the quality and suitability of products in accordance with technical rules, specifications, and standards stipulated in legislation
Post-market surveillance and pharmacovigilance, including adverse event monitoring and reporting
Import control for medical devices entering the Jordanian market
Labeling review to ensure compliance with local requirements
Enforcement of Good Manufacturing Practice (GMP) requirements for manufacturers supplying the Jordanian market

The Medical Devices and Supplies Directorate within the JFDA is the specific division responsible for overseeing medical device regulation. This directorate handles the registration process, classification determinations, technical review of submissions, and post-market surveillance activities.

Key Legal Instruments

Jordan's medical device regulatory framework is built on several key legal instruments:

Instrument	Scope
JFDA Law (2003)	Establishes the JFDA as an independent regulatory institution; defines its mandate over food, drugs, and medical devices
Drug and Pharmacy Law	Provides the broader legal framework for regulating health products, including provisions applicable to medical devices
Medical Devices Importation Regulations	Specific regulations governing the importation, registration, and distribution of medical devices in Jordan
JFDA Guidelines and Circulars	Operational guidance on registration procedures, documentation requirements, and technical standards

The JFDA operates a centralized online submission system. Applicants request an electronic appointment through the JFDA portal (application.jfda.jo) to initiate the registration process. This system facilitates structured workflow management and enables tracking of submissions through the review process.

Reliance on Reference Authorities

A defining feature of Jordan's medical device regulatory system is its heavy reliance on established reference authorities. The JFDA accepts CE marking (under the EU Medical Device Directive or EU MDR) and FDA clearance (510(k) clearance, De Novo grant, or PMA approval) as the primary basis for registration. This means that manufacturers who already hold CE certification or FDA clearance can leverage those approvals to streamline the Jordan registration process.

For devices that do not hold either a CE certificate or FDA clearance, the JFDA will accept a Free Sales Certificate from the country of origin, supplemented by a Free Sales Certificate from at least one of the following recognized countries: Switzerland, Australia, Canada, Norway, or the United Kingdom. This fallback pathway is available but involves additional documentation and may result in a longer review timeline.

Formal Definition of a Medical Device

The JFDA defines a medical device as every device, means, material, tool, item, reagent, and laboratory standard -- whether used alone or in combination with others, including the software necessary for its use -- prepared by the manufacturer for use by humans to achieve any of the following purposes, and which does not achieve its primary intended action by pharmacological, immunological, or metabolic means:

Diagnosis, prevention, monitoring, treatment, or mitigation of disease
Diagnosis, monitoring, mitigation, or compensation for injury or disability
Investigation, replacement, or modification of the anatomy or of a physiological process
Control of conception
Sterilization of medical devices, surfaces, and surgical kits
Providing information for a medical or diagnostic purpose by means of in vitro examination of specimens derived from the human body

This definition closely mirrors the EU MDR's medical device definition and is broadly consistent with the WHO/IMDRF framework. If your product falls within this definition, it is subject to JFDA registration requirements.

Device Classification in Jordan

Jordan uses a four-class risk-based classification system that closely mirrors the EU classification model. The system includes Classes I, IIa, IIb, and III, with classification determined by the intended purpose of the device, the degree of invasiveness, the duration of patient contact, and whether the device is active (requires a power source).

The JFDA accepts classification under both the EU MDR/MDD framework and the FDA classification system. Manufacturers should provide their existing classification rationale from their CE or FDA documentation as part of the Jordan registration submission. If a device already holds CE marking, the EU classification will generally be accepted by the JFDA. Similarly, if a device has FDA clearance, the FDA's classification can be mapped to the Jordanian system.

Classification Table

Class	Risk Level	Examples
Class I	Low risk	Bandages, surgical instruments, patient scales, surgical cameras, electric operating tables, cholesterol/uric acid test systems
Class Is (sterile)	Low risk (sterile)	Sterile surgical instruments, sterile dressings, sterile examination gloves
Class Im (measuring)	Low risk (measuring)	Patient scales, surgical microscopes, measuring calipers
Class IIa	Low-moderate risk	Surgical masks, surgical lamps, pregnancy self-testing devices, electric hospital beds
Class IIb	Moderate-high risk	Syringes, blood glucose self-testing devices, ECG devices, X-ray units, contact lenses, condoms
Class III	High risk	Stents, intraocular lenses (IOLs), defibrillators, pacemakers, HIV blood donor screening tests

Class I devices may carry sub-classifications based on specific characteristics: Class Is applies to sterile Class I devices, and Class Im applies to Class I devices with a measuring function. These sub-classes follow the EU MDD/MDR convention and are recognized by the JFDA. Devices in Class Is or Class Im may be subject to additional documentation requirements (e.g., sterilization validation for Class Is) compared to generic Class I devices.

Classification Principles

The classification system follows these general principles:

Non-invasive devices that contact intact skin only are generally Class I
Short-term invasive devices through body orifices are typically Class IIa
Surgically invasive devices used for short-term or long-term contact are generally Class IIb
Implantable devices and devices that sustain or support life are typically Class III
Active devices are classified based on the potential consequence of their failure and the degree of invasiveness
IVD devices are classified based on the risk to public health if the test fails and the personal health impact of an incorrect result

IVD Classification

In vitro diagnostic devices follow the same four-class structure. Classification considers the intended purpose of the test, its role in the diagnostic pathway, and the potential consequences of a false result:

IVD Class	Risk Level	Examples
Class I	Low risk	Specimen collection devices, general clinical chemistry reagents
Class IIa	Low-moderate risk	Pregnancy self-testing devices, basic clinical chemistry analyzers
Class IIb	Moderate-high risk	Blood glucose self-testing devices, clinical chemistry panels
Class III	High risk	HIV blood donor screening, hepatitis screening, blood typing reagents

Practical note: Do not assume that your Jordan classification will automatically match your EU or FDA classification. While the JFDA generally accepts EU and FDA classification models, the agency reserves the right to reclassify devices based on its own assessment of risk. Always confirm classification with your authorized representative or the JFDA before preparing your submission.

Registration Process Step-by-Step

Who Must Register and When

Registration is required before any medical device is placed on the Jordanian market. The obligation to register falls on both the manufacturer and the authorized representative (AR). In practice, the AR submits the application on the manufacturer's behalf, but the manufacturer is responsible for providing all required documentation and ensuring the accuracy of the submission. This applies to all device classes (I, IIa, IIb, and III) and to all foreign manufacturers without a legal entity in Jordan.

The JFDA registration process follows a defined sequence of steps. The process is the same for all device classes, but the depth of technical review and the timeline vary by risk class.

Step 1: Appoint an Authorized Representative

Foreign manufacturers that do not have a legal entity in Jordan must appoint an authorized representative (AR) -- also referred to as a local license holder or importer -- who is based in Jordan. The AR acts as the liaison between the manufacturer and the JFDA and is legally responsible for the device in the Jordanian market. The AR holds the registration on behalf of the foreign manufacturer and is the entity that submits the registration application to the JFDA.

Key requirements for the AR:

Must be a Jordanian legal entity registered with the relevant authorities
Must hold a valid import license for medical devices
Must be appointed through a formal, notarized agency agreement between the manufacturer and the AR
The agency agreement should be legalized from the manufacturer's side through the chamber of commerce, notary public, ministry of justice, ministry of foreign affairs, and the Jordanian Embassy (or the nearest Jordanian diplomatic mission)

Step 2: Request an Electronic Appointment

The AR requests an electronic appointment through the JFDA's online portal at application.jfda.jo/Cosmo (the JFDA's Cosmo electronic submission system). This appointment initiates the formal registration process and secures a place in the JFDA's review queue.

Step 3: Pay Registration Fees

The applicant pays the required registration fees. Fees must be paid in full before the application can proceed to the review stage. A payment receipt confirming that applicable fees have been paid should be included with the submission.

Step 4: Prepare and Submit the Application

The AR completes the JFDA application form and assembles all required documentation (detailed in the next section). The complete dossier is submitted to the JFDA for review. All documents must be legible, and the page size should be uniform. Documents in languages other than Arabic or English must be accompanied by a certified translation.

Step 5: JFDA Review

The JFDA's Medical Devices and Supplies Directorate conducts a review of the submission. The review process includes:

Administrative review: Verification that all required documents are present and complete
Technical review: Assessment of the device's safety and efficacy based on the submitted documentation, including review of the CE or FDA certification, quality system documentation, and product specifications
Sample importation and laboratory analysis: For many devices -- particularly higher-risk devices and IVDs -- the JFDA requires that samples be imported and analyzed at the JFDA's quality control laboratory before registration can be granted. The AR coordinates the import of the required samples, and the JFDA issues a sample import permit. The laboratory then conducts testing to verify that the product meets the claimed specifications. This step adds both time and cost to the process and should be planned for in advance

If deficiencies are identified during the review, the JFDA will issue a deficiency letter to the applicant. The applicant is typically granted a 30-day period to address the identified deficiencies and submit the requested additional information. If the applicant fails to respond within this period, the application may be rejected. With the approval of the Registration Authority (RA) Manager, the JFDA may extend the deadline for an additional 30 days.

Step 6: Registration Decision

If the JFDA determines that the device meets all applicable requirements, a registration certificate is issued to the authorized representative. The registration certificate is valid for 5 years from the date of issue.

If the application is rejected, the applicant has the right to submit an objection to the Medical Device Committee within 30 working days from the date of being notified of the committee's decision. This objection process provides an important avenue for manufacturers to contest registration decisions and present additional evidence in support of their application.

Step 7: License Renewal

Registration certificates must be renewed before expiration. The renewal process requires updated documentation, including current CE or FDA certificates, updated ISO certificates, and any changes to the device or its manufacturing process since the original registration. Manufacturers should begin the renewal process at least 6 months before the expiration date to ensure continuity of market access.

Required Documentation

The JFDA requires a comprehensive set of documents for medical device registration. The following table details each required document along with guidance on its preparation.

Document	Description and Guidance
CE Certificate or FDA Certificate (CFG)	Original notarized copy of the CE certificate (issued by an EU Notified Body) or FDA Certificate of Foreign Government (CFG). This is the primary evidence of regulatory clearance from a recognized reference authority.
EC Full Quality Assurance and Design Examination Certificates (Class III only)	For Class III devices, both the EC Full Quality Assurance certificate and the Design Examination certificate must be submitted. This reflects the higher scrutiny applied to high-risk devices.
Declaration of Conformity	The manufacturer's Declaration of Conformity, confirming that the device meets the essential requirements of the applicable EU directive or regulation. Must be signed by an authorized representative of the manufacturer.
ISO Certificate	Valid ISO 13485 certificate (or equivalent quality management system certification) covering the manufacturing site. The certificate must be current and issued by an accredited certification body.
Free Sales Certificate (FSC)	Certificate of Free Sale from the country of origin, confirming that the device is legally marketed in the country of manufacture. For devices without CE or FDA certification, an additional FSC from one of the following countries is required: Switzerland, Australia, Canada, Norway, or the United Kingdom.
Composition Certificate	Certificate from the manufacturer detailing the composition or formulation of the device. Must be signed and stamped by the manufacturer.
Finished Product Specification	Detailed specification for the finished product, including physical, chemical, and performance parameters. Must include a reference number and date.
Shelf Life and Storage Declaration	Manufacturer's declaration of the product's shelf life and recommended storage conditions (temperature, humidity, light exposure).
Certificate of Analysis (CoA)	Certificate of Analysis for a specific production batch, including the production date, expiry date, and batch number. This document provides evidence of product quality and consistency.
Method of Analysis	Detailed description of the analytical methods used for quality control testing of the finished product.
BSE/TSE Certificate	Certificate confirming that the device does not contain, or is free from, bovine spongiform encephalopathy (BSE) and transmissible spongiform encephalopathy (TSE) risk materials. Particularly important for devices containing or contacting animal-derived materials.
Stability Study	Stability study data covering the full claimed shelf life. The study should demonstrate that the device maintains its specified performance characteristics throughout the claimed shelf life under the stated storage conditions.
Inner and Outer Labels	Copies of both the inner (immediate container) and outer (shipping carton) labels as they will appear on the marketed product in Jordan. Labels must comply with JFDA labeling requirements.
Instructions for Use (IFU)	Complete instructions for use (user manual) as provided with the device. The IFU should cover all intended uses, contraindications, warnings, precautions, and operating instructions.
Catalogue	Product catalogue or brochure describing the device and its intended applications.

Additional Documents That May Be Required

Depending on the device type and risk class, the JFDA may request additional documentation during the review process, including:

Clinical data or clinical evaluation reports supporting the device's safety and performance claims
Risk analysis documentation per ISO 14971
Sterilization validation reports for sterile devices
Biocompatibility testing data per ISO 10993
Electrical safety and electromagnetic compatibility (EMC) test reports for active devices
Software validation documentation for devices incorporating software

Document Preparation Tips

All documents must be legible and of uniform page size
Documents in Arabic or English are accepted. Documents in other languages must be accompanied by a certified translation into English from an authorized translation office
Original certificates (CE, FDA, ISO) should be notarized copies
Ensure all certificates are current and valid at the time of submission; expired certificates will result in rejection or requests for additional information
The composition certificate and finished product specification must be signed and stamped by the manufacturer

Authorized Representative Requirements

The authorized representative is a central figure in the Jordanian medical device registration process. Foreign manufacturers cannot register devices directly with the JFDA; they must work through a Jordanian-based AR who serves as the legal entity responsible for the device in the Jordanian market.

Role and Responsibilities

The AR's responsibilities include:

Submitting the registration application to the JFDA on behalf of the foreign manufacturer
Holding the registration certificate for the device in Jordan
Serving as the point of contact between the manufacturer and the JFDA for all regulatory communications
Managing import logistics, including coordination with customs and the JFDA for device clearance
Handling adverse event reporting and field safety corrective actions in coordination with the manufacturer
Maintaining registration records and managing the renewal process
Coordinating with the JFDA on any post-market surveillance activities, recalls, or regulatory inquiries

Selecting an Authorized Representative

Choosing the right AR is a critical business decision with lasting regulatory implications. Consider the following factors:

Regulatory expertise: The AR should have demonstrable experience with medical device registration in Jordan and familiarity with the JFDA's processes, requirements, and personnel
Import license and infrastructure: The AR must hold a valid medical device import license and have the warehousing and distribution infrastructure to handle your products
Track record: Request references from other foreign manufacturers the AR represents. A strong track record with the JFDA can expedite the review process
Communication and responsiveness: The AR will be your primary interface with the JFDA. Ensure they have the capacity and commitment to communicate promptly and transparently
Exclusivity considerations: Some ARs insist on exclusive representation, while others are willing to represent multiple manufacturers in the same therapeutic area. Clarify exclusivity terms before signing the agreement
Agreement terms: The AR agreement should clearly define the scope of services, fee structure, termination provisions, and responsibilities of each party

Agency Agreement Legalization

The agency agreement between the manufacturer and the AR must be legalized through a specific chain of authentication:

Notarization by a local notary public in the manufacturer's country
Authentication by the local chamber of commerce
Authentication by the ministry of justice in the manufacturer's country
Authentication by the ministry of foreign affairs in the manufacturer's country
Legalization by the Jordanian Embassy (or the nearest Jordanian diplomatic mission)

If there is no Jordanian Embassy in the manufacturer's country, legalization can be obtained from any Jordanian Embassy in a nearby country. This legalization chain is mandatory -- the JFDA will not accept agency agreements that have not been properly legalized.

Fees and Timeline

Registration Timeline

The JFDA's review timeline varies by device classification. Higher-risk devices require more extensive technical review and, in some cases, laboratory analysis, which extends the overall timeline.

Device Class	Estimated Timeline
Class I (sterile or measuring function)	4 months
Class I (other, excluding export-only devices)	4 months
Class IIa	4 months
Class IIb	4-8 months
Class III	8 months

These timelines represent the JFDA's standard review period from the date of complete submission. Timelines may be extended if:

The JFDA requests additional information or clarification, and the 30-day response period applies
Laboratory analysis of product samples is required
The application is incomplete or contains deficiencies that must be addressed

Manufacturers should plan for additional time before the review period for document preparation, AR appointment and agreement legalization, and submission logistics. A realistic total timeline from project initiation to registration certificate receipt is 6-12 months for most devices, depending on the risk class and the readiness of the documentation package.

Registration Fees

The JFDA charges registration fees for the review and processing of medical device registration applications. Fees are subject to change and should be verified with the JFDA or your authorized representative at the time of application.

Fee Category	Approximate Amount
Registration fee	~USD 142 per application
Additional laboratory analysis fee (if required)	~USD 211 per product

Total Cost Considerations

When budgeting for Jordan market entry, manufacturers should account for costs beyond the JFDA registration fees:

Cost Component	Estimated Range
JFDA registration fee	~USD 142-353 (depending on whether lab analysis is needed)
Authorized representative fees	Varies; typically annual retainer plus per-registration fees
Document preparation and legalization	USD 500-2,000 (including agency agreement legalization, certified translations, notarization)
Shipping of samples (for lab analysis)	USD 200-1,000 (depending on device size and shipping origin)
Regulatory consulting (if used)	USD 2,000-8,000 per registration

Labeling and Language Requirements

Labeling compliance is a critical component of the JFDA registration process. All medical devices marketed in Jordan must meet specific labeling requirements.

Language Requirements

The JFDA's labeling requirements have two important dimensions:

Arabic language: Labels must include Arabic language information. Jordan is an Arabic-speaking country, and the JFDA requires that critical safety and identification information be accessible to local healthcare professionals and patients. At minimum, key labeling elements such as the device name, manufacturer name, warnings, and storage instructions should appear in Arabic.
English language: Labeling must also be provided in English, as this is the primary language of the technical documentation and regulatory correspondence. The sponsor's (authorized representative's) name and contact information must be included on the labeling.

In practice, most manufacturers provide bilingual labeling (Arabic and English) to satisfy both requirements. Manufacturers should confirm the current language requirements in detail with their authorized representative or the JFDA at the time of registration, as specific requirements may vary by device type and risk class.

Required Labeling Elements

Labels for medical devices marketed in Jordan should include the following information:

Device name (trade name and common name)
Manufacturer's name and address
Authorized representative's name and contact information in Jordan
Device classification (Class I, IIa, IIb, or III)
Intended use / indications for use
Contraindications, warnings, and precautions
Instructions for storage and handling
Shelf life / expiration date
Batch or lot number
Sterilization method (for sterile devices)
Single-use or reusable designation
CE mark or FDA clearance number (as applicable)
Country of manufacture

IFU Requirements

The Instructions for Use (IFU) must be comprehensive and include:

Detailed operating instructions
Safety warnings and precautions
Installation and setup instructions (for active devices)
Maintenance and cleaning instructions
Troubleshooting guidance
Disposal instructions
Electromagnetic compatibility information (for active devices)

Both the inner label (immediate container) and outer label (shipping carton) must be submitted as part of the registration dossier. The JFDA reviews labeling as part of the technical review process, and non-compliant labeling is a common source of deficiency queries.

Post-Market Obligations

Once a medical device is registered and placed on the Jordanian market, both the manufacturer and the authorized representative have ongoing regulatory obligations. The JFDA maintains an active post-market surveillance program to monitor the safety and performance of marketed devices.

Adverse Event Reporting

The JFDA requires reporting of adverse incidents involving medical devices. The reporting system applies to:

Manufacturers who become aware of adverse incidents involving their devices in Jordan
Authorized representatives who receive reports of adverse incidents from healthcare providers, patients, or other sources
Healthcare facilities including hospitals, pharmacies, and health care centers

The JFDA provides an Adverse Incident Reporting Form through its online services portal (services.jfda.jo). Reports can be submitted by hospitals, pharmacies, and health care centers. The form captures details about the reporting body, the device involved, the incident description, and any patient outcomes.

Pharmacovigilance System

Jordan operates a national pharmacovigilance system through the JFDA's Rational Drug Use and Pharmacovigilance Department. While pharmacovigilance activities are primarily associated with pharmaceuticals, the JFDA's pharmacovigilance system also encompasses medical device adverse event monitoring. The JFDA has published guidelines for detecting and reporting adverse drug reactions and maintains a national pharmacovigilance database that tracks safety signals across all regulated health products.

Manufacturers and authorized representatives should:

Establish a clear process for receiving, documenting, and reporting adverse events from Jordan
Maintain records of all adverse events reported in Jordan, regardless of severity
Submit timely reports of serious adverse events to the JFDA
Cooperate with the JFDA on any field safety corrective actions (recalls, urgent safety alerts, product modifications)

Post-Market Surveillance Activities

The JFDA conducts post-market surveillance through several mechanisms:

Random sampling and testing of marketed medical devices at the JFDA's quality control laboratory
Inspection of distribution channels to verify compliance with storage and handling requirements
Review of labeling and advertising to ensure ongoing compliance with JFDA requirements
Monitoring of adverse event reports and safety signals through the national pharmacovigilance system

Field Safety Corrective Actions

If a manufacturer initiates a field safety corrective action (FSCA) -- such as a product recall, safety alert, or product modification -- in any market where the device is sold, the authorized representative must notify the JFDA promptly. The notification should include:

Description of the issue and the risk to patients or users
Scope of affected devices in Jordan (lot numbers, serial numbers, quantities)
Proposed corrective action plan
Communication plan for affected healthcare facilities and users

The JFDA may require additional corrective actions specific to the Jordanian market, depending on the nature and severity of the issue.

Registration Maintenance

Maintaining an active registration in Jordan requires ongoing attention:

License renewal: Registration certificates must be renewed every 5 years. The renewal process requires submission of updated documentation and payment of renewal fees
Importer/Manufacturer License: In addition to the device registration certificate, the authorized representative (or local manufacturer) must maintain a valid importer or manufacturer license. This license has its own validity period and renewal requirements, which are separate from the device registration. Ensure your AR keeps this license current, as a lapsed import license prevents the legal distribution of your device regardless of the device registration status
Change notifications: Significant changes to the device, manufacturing process, or quality system must be reported to the JFDA. Depending on the nature of the change, a supplementary submission or re-registration may be required
Certificate updates: If the manufacturer's CE certificate, FDA clearance, or ISO certificate is renewed or reissued, updated copies should be provided to the JFDA through the authorized representative

Tips for Foreign Manufacturers

1. Start with CE or FDA Clearance

Jordan's regulatory system is built on the principle of reliance on established reference authorities. Having a current CE certificate (under the EU MDR or, where still valid, the MDD/IVDD) or FDA clearance (510(k), De Novo, or PMA) is the single most important factor in simplifying and expediting your Jordan registration. Manufacturers who attempt to register without either credential face additional documentation requirements, longer timelines, and a higher likelihood of queries from the JFDA.

If you are planning a multi-market launch strategy that includes Jordan, prioritize obtaining CE marking or FDA clearance before initiating the Jordan registration process. The investment in these reference market clearances pays dividends across dozens of markets that use reliance pathways.

2. Choose Your Authorized Representative Carefully

Your AR is your regulatory representative, your import channel, and your commercial partner in Jordan. The quality of your AR relationship directly impacts the speed and success of your registration. Take the time to evaluate multiple candidates, check references from other manufacturers they represent, and negotiate clear terms in the agency agreement.

A common mistake is selecting an AR based solely on the lowest fee, only to discover that the AR lacks the regulatory expertise or JFDA relationships needed to navigate complex queries or objections. The difference between a good AR and a poor one can mean the difference between a 4-month registration and a 12-month ordeal.

3. Prepare Complete Documentation Before Submission

The JFDA's review process is front-loaded: the quality of your initial submission determines the speed and outcome of the review. Incomplete submissions trigger deficiency letters, 30-day response periods, and potential rejection. Before submitting, conduct a thorough internal review of your documentation package against the JFDA's requirements.

A practical approach is to create a document checklist based on the required documents table above and verify that every item is present, current, properly formatted, and correctly legalized before authorizing your AR to submit.

4. Factor in Legalization Time

The agency agreement legalization process -- notarization, chamber of commerce authentication, ministry of justice authentication, ministry of foreign affairs authentication, and Jordanian Embassy legalization -- can take 4-8 weeks depending on the country and the efficiency of the relevant authorities. Build this timeline into your project plan from the outset.

5. Budget for Laboratory Analysis

For certain device types, particularly IVDs and higher-risk devices, the JFDA may require samples for analysis at its quality control laboratory. This requirement adds both time and cost to the registration process. Budget for sample preparation, shipping, and the additional analysis fee when planning your Jordan market entry.

6. Leverage Your Middle East Registration Strategy

If you are already registered or planning to register in Saudi Arabia (SFDA), the UAE, or other GCC markets, you can leverage documentation and experience from those markets for your Jordan registration. While the JFDA has its own specific requirements, many of the underlying documents -- CE certificates, ISO certificates, Free Sales Certificates, technical files, IFUs -- are the same across the region. A coordinated Middle East registration strategy can reduce duplication and accelerate time-to-market across multiple countries.

7. Monitor Regulatory Changes

Jordan's regulatory framework is evolving. The JFDA periodically updates its guidelines, fee structures, and procedural requirements. Stay informed about regulatory changes through your authorized representative, industry associations, and the JFDA's official website (www.jfda.jo). Changes in reference market requirements -- particularly EU MDR implementation deadlines and FDA policy changes -- can also affect Jordan registration requirements.

8. Use the Objection Process if Needed

If your registration application is rejected, you have the right to submit an objection to the Medical Device Committee within 30 working days of receiving the decision. This objection process is a formal mechanism for presenting additional evidence, clarifying misunderstandings, or challenging the committee's rationale. Do not hesitate to use this process if you believe the rejection was based on incomplete information or an incorrect assessment.

9. Plan for Renewal Early

Registration certificates are valid for 5 years. Begin the renewal process at least 6 months before expiration to ensure continuity of market access. A lapsed registration means your device cannot be legally sold in Jordan until the renewal is granted, which can disrupt supply to hospitals and clinics and damage your commercial relationships.

10. Understand the Market Dynamics

Jordan's healthcare procurement system includes both public sector tenders (managed by the Ministry of Health and other government entities) and private sector purchasing. Registration with the JFDA is a prerequisite for participation in both channels, but success in the public sector often requires additional steps such as listing on government procurement lists and meeting local pricing requirements. Work with your AR to understand the procurement landscape and develop a commercial strategy that aligns with your regulatory timeline.

Summary

Jordan's JFDA medical device registration process is structured, predictable, and heavily reliant on established reference authority approvals. For manufacturers who already hold CE marking or FDA clearance, the pathway to Jordanian market access is relatively straightforward: appoint a qualified authorized representative, assemble the required documentation package, submit through the JFDA's online system, and engage constructively with the review process.

The key elements to remember:

Classification follows the EU model (I, IIa, IIb, III)
Timeline ranges from 4 months (Class I and IIa) to 8 months (Class III)
Registration is valid for 5 years and must be renewed before expiration
An authorized representative in Jordan is mandatory for all foreign manufacturers
CE or FDA certification is the primary basis for registration
English labeling is required, with the sponsor's information included
Post-market obligations include adverse event reporting and registration maintenance

Jordan's medical device market, while smaller than those of Saudi Arabia or the UAE, offers meaningful commercial potential with lower competitive intensity. Its strategic location, growing healthcare infrastructure, and increasingly mature regulatory system make it a worthwhile addition to any Middle East market entry strategy.

Next steps: For guidance on registration in other Middle Eastern markets, see our guides to medical device registration in Saudi Arabia, UAE, and the GCC, Israel AMAR registration, and Saudi Arabia SFDA MDMA.